Experimental vaccine against Ebola generates good response after clinical trial

The first experimental vaccine against the Ebola virus was well tolerated and generated a good immune response, showed the first results of a clinical trial in the United States, published on Wednesday. The experimental vaccine virus did not cause serious side effects and...

Clinical trials of vaccine against the Ebola virus begin on November 1

The World Health Organization (WHO) said this Tuesday it will begin on November 1 clinical trials in Switzerland of one of the two candidate vaccines against Ebola. The vaccine is the NIAID / GSK, developed by GlaxoSmithKline, which at the moment is already being tested on...

Ebola vaccine is not expected before January of 2015

The World Health Organization (WHO) said that a vaccine for ebola is not expected  until January. Such treatments would begin to be tested in the countries affected by the disease in West Africa in early 2015. Currently, sixty people are participating in a clinical trial at the...